EIF2AK4 and cancer: Collectively, these results identify that activation of the ISR is toxic for multidrug‐resistant FBXW7‐deficient cancer cells, and suggest that the effects of several anticancer drugs might be partly mediated by a previously unknown property of these compounds in activating the GCN2‐dependent branch of the ISR.